Turner Institute for Brain and Mental Health, School of Psychological Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia.
Women's Mental Health Service, Royal Women's Hospital, Melbourne, VIC, Australia.
Sleep. 2024 Aug 14;47(8). doi: 10.1093/sleep/zsae106.
Insomnia symptoms are common during the perinatal period and are linked to adverse outcomes. This single-blind three-arm randomized-controlled trial examined whether two interventions targeting different mechanisms prevent postpartum insomnia.
Participants were nulliparous females 26-32 weeks gestation with Insomnia Severity Index (ISI) scores ≥ 8, recruited in Australia and randomized 1:1:1 to: (1) a responsive bassinet (RB) designed to support infant sleep and reduce maternal sleep disruption until 6 months postpartum, (2) therapist-assisted cognitive behavioral therapy for insomnia (CBT-I) delivered during pregnancy and postpartum, or (3) a sleep hygiene booklet (control; CTRL). Outcomes were assessed at baseline (T1), 35-36 weeks gestation (T2), and 2, 6, and 12 months postpartum (T3-T5). The primary outcome was ISI scores averaged T3-T5. Primary analyses were regressions controlling for baseline outcomes.
One hundred and twenty-seven participants (age M ± SD = 32.62 ± 3.49) were randomized (RB = 44, CBT-I = 42, CTRL = 41). Both interventions were feasible and well-accepted, with few related adverse events reported. Compared to CTRL, the average ISI across T3-T5 was lower for CBT-I (p = .014, effect size [ES] = 0.56, medium) but not RB (p = .270, ES = 0.25, small). Exploratory findings on maternal insomnia diagnosis, sleep disturbance, sleep-related impairment, beliefs and attitudes about sleep, depression, anxiety, as well as infant sleep outcomes were also presented.
CBT-I but not RB reduced prenatal insomnia (very large effect) and prevented postpartum insomnia (medium effect). Further research is needed to examine the effects of both CBT-I and RB on other outcomes such as sleep-related well-being, postpartum depression, and maternal postpartum sleep duration.
The Study for Mother-Infant Sleep (The SMILE Project): reducing postpartum insomnia using an infant sleep intervention and a maternal sleep intervention in first-time mothers. https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=377927, Australian New Zealand Clinical Trials Registry: ACTRN12619001166167.
围产期常见失眠症状,并与不良结局相关。本单盲三臂随机对照试验旨在探讨两种针对不同机制的干预措施是否能预防产后失眠。
研究对象为澳大利亚招募的 26-32 孕周、失眠严重指数(ISI)评分≥8 的初产妇,随机分为 1:1:1 三组:(1)响应式婴儿床(RB),旨在支持婴儿睡眠并减少母亲睡眠中断,直至产后 6 个月;(2)孕期和产后提供的治疗师辅助认知行为疗法治疗失眠(CBT-I);(3)睡眠卫生小册子(对照组;CTRL)。在基线(T1)、35-36 孕周(T2)和产后 2、6、12 个月(T3-T5)进行评估。主要结局是 T3-T5 的平均 ISI 评分。主要分析是在控制基线结局的情况下进行回归。
127 名参与者(年龄 M±SD=32.62±3.49)被随机分配(RB=44,CBT-I=42,CTRL=41)。两种干预措施均可行且被广泛接受,仅报告了少数相关不良事件。与 CTRL 相比,CBT-I 组的平均 ISI 在 T3-T5 期间较低(p=0.014,效应量[ES]为 0.56,中等),而 RB 组则没有(p=0.270,ES=0.25,小)。还报告了关于母亲失眠诊断、睡眠障碍、睡眠相关损害、对睡眠的信念和态度、抑郁、焦虑以及婴儿睡眠结果的探索性发现。
CBT-I 而非 RB 降低了产前失眠(非常大的影响)并预防了产后失眠(中等影响)。需要进一步研究来检验 CBT-I 和 RB 对其他结果的影响,如睡眠相关幸福感、产后抑郁和母亲产后睡眠时间。
母婴睡眠研究(SMILE 项目):首次生育的母亲使用婴儿睡眠干预和母亲睡眠干预来减少产后失眠。https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=377927,澳大利亚新西兰临床试验注册中心:ACTRN12619001166167。